Antony A Riley's Net Worth

$3.05 Million

Estimate Recalculated Sep 13, 2024 09:46PM EST

Who is Antony A Riley

Antony A Riley has an estimated net worth of $3.05 Million. This is based on reported shares across multiple companies, which include Forte Biosciences, Inc., Krystal Biotech, Inc., and AVANEX CORP.

SEC CIK

Antony A Riley's CIK is 0001339375

Past Insider Trading and Trends

2006 was Antony A Riley's most active year for acquiring shares with 7 total transactions. Antony A Riley's most active month to acquire stocks was the month of February. 2006 was Antony A Riley's most active year for disposing of shares, totalling 6 transactions. Antony A Riley's most active month to dispose stocks was the month of March. 2023 saw Antony A Riley paying a total of $149,999.14 for 326,639 shares, this is the most they've acquired in one year. In 2021 Antony A Riley cashed out on 25,000 shares for a total of $106,105.48, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Forte Biosciences, Inc.

CHIEF FINANCIAL OFFICER
Updated Jul 03, 2024
Form 4
-1.12%
-3.35K
$0.55
-$1.83K
Jul 03, 2024
294.25K
Options
Jul 01
Form 4
-1.11%
-3.35K
$0.71
-$2.37K
Apr 02, 2024
297.60K
Options
Apr 01
Form 4
350.00K
Mar 25, 2024
350.00K
Grant
Mar 21
Form 4
-1.26%
-3.84K
$0.82
-$3.16K
Jan 03, 2024
300.94K
Options
Jan 01
Form 4
-1.05%
-3.24K
$0.66
-$2.15K
Oct 03, 2023
304.79K
Options
Oct 01
Form 4
525.49%
148.51K
$1.01
$150.00K
Aug 02, 2023
176.78K
Grant
Jul 31
Form 4
-2.04%
-3.24K
$1.04
-$3.37K
Jul 05, 2023
156.01K
Options
Jul 01
Form 4
-1.99%
-3.24K
$1.01
-$3.27K
Apr 04, 2023
159.25K
Options
Apr 01
Form 4
150.00K
Feb 27, 2023
150.00K
Grant
Feb 25
Form 4
75.00K
Jan 18, 2022
75.00K
Grant
Jan 17
Form 4
-69.32%
-25.00K
$4.24
-$106.11K
Sep 07, 2021
11.07K
Sale
Sep 07
Form 4
42.50K
Apr 13, 2021
42.50K
Grant
Apr 09
Form 4
278.22%
81.70K
$14.39
$96.45K
Jun 30, 2020
111.07K
Purchase
Jun 26 - Jun 30
Form 3
Jun 17, 2020
29.37K
Showing 14 results

Krystal Biotech, Inc.

Chief Financial Officer
Updated Nov 21, 2019
Form 4
$9.85
$61.56K
Nov 21, 2019
27.80K
Options
Nov 19
Form 4
25.00K
Jun 17, 2019
25.00K
Grant
Jun 01
Form 4
25.00K
Mar 25, 2019
25.00K
Grant
Mar 22
Form 4
27.80K
$10.75
$30.10K
May 24, 2018
27.80K
Purchase
Mar 08 - May 22
Form 3
May 24, 2018
Showing 5 results

AVANEX CORP

V.P., Finance
Updated Apr 03, 2007
Form 4
$28.26
Apr 03, 2007
183.28K
Options
Mar 31
Form 4
18.00%
10.71K
Mar 22, 2007
70.24K
Grant
Mar 21
Form 4
$28.26
Jan 04, 2007
172.57K
Options
Dec 31
Form 4
942.35%
28.26K
$1.65
$46.63K
Oct 04, 2006
31.26K
s
ScheduledOct 02
Form 4
1.52%
3.00K
$0.10
$3.24K
Oct 03, 2006
200.83K
Options
Aug 15 - Sep 30
Form 4
$28.26
Jul 11, 2006
197.83K
Options
Jun 30
Form 4
-100.00%
-16.21K
$1.99
-$32.25K
May 15, 2006
Sale
May 11
Form 4
-5.33%
-12.05K
$3.15
-$37.94K
Apr 04, 2006
214.03K
Options
Mar 31
Form 4
226.09K
Feb 06, 2006
226.09K
Grant
Feb 01
Form 4
350.00K
Sep 22, 2005
350.00K
Grant
Sep 20
Form 3
Sep 22, 2005
Showing 11 results